25324
document
Plasmakinetic prostate resection in the treatment of benign prostate hyperplasia : results of 1-year follow up . AIM In our randomized prospective study , we aimed to evaluate the efficiency of plasmakinetic resection of prostate ( PKRP ) by comparing the preoperative and postoperative results of the transurethral resection of prostate ( TURP ) and PKRP techniques which we administered in patients with benign prostate hyperplasia ( BPH ) in our clinic . METHODS Of 57 patients for whom we thought an operative intervention was necessary , 30 cases in the first group had a TURP and 24 cases in the second group had a PKRP . International prostate symptom scores ( I-PSS ) , uroflowmetry , measurement of residual urine amount and ultrasonography were performed for each patient both preoperatively and postoperatively ( first month and first year ) . Operation times , urethral catheterization times , preoperative and postoperative Hb , Htc and serum Na values of the patients were compared and the complications of the groups were also compared . RESULTS On first month and first year follow up between the groups , there was no significant statistical difference in I-PSS , maximum flow rate , average flow , residual urine and size of the prostate . The decrease in serum Na level was found to be significantly higher in the TURP group ( P < 0.05 ) . The operation times were not significantly different between the groups . While the postoperative catheterization time was 75.7 h in TURP group , it was found to be 42 h in PKRP group and it was clear that catheterization time was significantly shorter ( P < 0001 ) . CONCLUSION It is obvious that PKRP is as efficient as TURP and it has a similar morbidity . In our opinion , PKRP makes a promising treatment for BPH with its advantages , such as early removal of postoperative urethral catheter , a shorter hospital stay and the absence of TUR syndrome risk .
25325
Intervention_Surgical
Plasmakinetic prostate resection
25326
Intervention_Surgical
plasmakinetic resection of prostate ( PKRP )
25327
Intervention_Surgical
transurethral resection of prostate
25328
Intervention_Surgical
TURP
25329
Intervention_Surgical
PKRP
25330
Intervention_Surgical
PKRP
25331
Intervention_Surgical
PKRP
25332
Outcome_Physical
International prostate symptom scores ( I-PSS )
25333
Outcome_Physical
uroflowmetry
25334
Outcome_Other
measurement of
25335
Outcome_Physical
residual urine amount
25336
Outcome_Other
and ultrasonography
25337
Outcome_Other
Operation times
25338
Outcome_Other
urethral catheterization times
25339
Outcome_Physical
preoperative and postoperative Hb
25340
Outcome_Other
,
25341
Outcome_Physical
Htc and serum Na values
25342
Outcome_Physical
I-PSS
25343
Outcome_Physical
maximum flow rate
25344
Outcome_Physical
average flow
25345
Outcome_Physical
residual urine and size of the prostate
25346
Outcome_Physical
serum Na level
25347
Outcome_Other
operation times
25348
Outcome_Other
postoperative catheterization time
25349
Outcome_Other
catheterization time
25350
Participant_Sample-size
hyperplasia
25351
Participant_Sample-size
57